Treatment of inflammatory bowel disease
AssigneeThe University of Queensland
InventorsTrent Woodruff, Steven Taylor, David Fairlie
Life of this patent
Estimating the term…
Abstract
This invention relates to methods of treatment of inflammatory bowel disease, and especially to treatment of this condition with cyclic peptidic and peptidomimetic compounds which have the ability to modulate the activity of G protein-coupled receptors. The compounds preferably act as antagonists of the C5a receptor, and are active against C5a receptors on polymorphonuclear leukocytes and macrophages. Particularly preferred compounds for use in the methods of the invention are disclosed.
Claims23
A method of treatment of inflammatory bowel disease, comprising the step of administering an effective amount of an inhibitor of a G protein-coupled receptor to a subject in need of such treatment, in which the inhibitor is a compound which
- (a) is an antagonist of a G protein-coupled receptor,
- (b) has substantially no agonist activity, and
- (c) is a cyclic peptide or peptidomimetic compound of formula I
- where A is H, alkyl, aryl, NH2, NH-alkyl, N(alkyl)2, NH-aryl, NH-acyl, NH-benzoyl, NHSO3, NHSO2-alkyl, NHSO2-aryl, OH, O-alkyl, or O-aryl;
- B is an alkyl, aryl, phenyl, benzyl, naphthyl or indole group, or the side chain of a D- or L-amino acid, but is not the side chain of glycine, D-phenylalanine, L-homophenylalanine, L-tryptophan, L-homotryptophan, L-tyrosine, or L-homotyrosine;
- C is the side chain of a D-, L- or homo-amino acid, but is not the side chain of isoleucine, phenylalanine, or cyclohexylalanine;
- D is the side chain of a neutral D-amino acid, but is not the side chain of glycine or D-alanine, a bulky planar side chain, or a bulky charged side chain;
- E is a bulky substituent, but is not the side chain of D-tryptophan, L-N-methyltryptophan, L-homophenylalanine, L-2-naphthyl L-etrahydroisoquinoline, L-cyclohexylalanine, D-leucine, L-fluorenylalanine, or L-histidine;
- F is the side chain of L-arginine, L-homoarginine, L-citrulline, or L-canavanine, or a bioisostere thereof;
- and
- X is —(CH2)nNH— or (CH2)n—S—, where n is an integer of from 1 to 4;
- —(CH2)2O—;
- —(CH2)3O—;
- —(CH2)3—;
- —(CH2)4—;
- —CH2COCHRNH—;
- or —CH2—CHCOCHRNH—, where R is the side chain of any common or uncommon amino acid.
Dependencies are inferred from the claim text.